Document is current
Any future updates will be listed below
-
Authors
Mallah, Khalil
Couch, Christine
Alshareef, Mohammed
Borucki, Davis
Yang, Xiaofeng
Alawieh, Ali
Tomlinson, Stephen http://orcid.org/0000-0002-6281-2122
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs (1BX004256, 1RX001141, IK6BX005235)
National Institutes of Health (T32AI132164)
National Center for Advancing Translational Sciences (TL1 TR001451, UL1 TR001450)
Neurosurgery Research and Education Foundation
- License Information
-
More Information
Article History
Received: 11 March 2021
Accepted: 10 April 2021
First Online: 20 April 2021
Declarations
:
: All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) at the Medical University of South Carolina and Ralph H. Johnson VA Medical Center.
: ST is an inventor on a licensed patent for CR2-targeted complement inhibition.
